	Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer. Expert Rev Mol Med Chen M, Zhu Y, Wang B, Zhang L, Chen B, Shi X, Cui E. PMID: 42426556 [PubMed - as supplied by publisher]
	Automated Analysis of Liquid Biopsy Using Deep Learning: Detecting Circulating Tumor Cells and Cancer-Associated Fibroblasts. Methods Mol Biol Shen C, Zhou H, Lin S, Williams A, Yang C, Cote RJ. PMID: 42426467 [PubMed - in process]
	Bioinformatics of Shallow Whole Genome Sequencing Data of Circulating Tumor Cells to Inform Cancer Diagnosis and Treatment. Methods Mol Biol Silvestri M, Reduzzi C, De Marco C, Cristofanilli M, Pruneri G, Di Cosimo S. PMID: 42426466 [PubMed - in process]
	Prognostic factors and the role of pelvic lymph node dissection in oligometastatic prostate cancer: a multicenter exploratory study. Surg Endosc Hu J, Yuan Y, Zou X, Liu X, Liu W, Dong Y, Wang B, Fu B. PMID: 42426390 [PubMed - as supplied by publisher]
	G6PD: An Old Player with Multiple Emerging Roles from Cancer Progression to Metastasis and Chemoresistance. Protein J Kanwal L, Haer V, Anum H, Ali S. PMID: 42426331 [PubMed - as supplied by publisher]
	Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer. Nat Rev Urol Fletcher SA, Pickersgill NA, Osorio JC, McHugh DJ, Nagar H, Kole T, Janopaul-Naylor J, Lacuna K, Eastham JA, Touijer KA, Fainberg JS, Scher HI, Ehdaie B, Dallos MC, Gaffney CD. PMID: 42426291 [PubMed - as supplied by publisher]
	Repositioning osteocytes as integrative regulators of breast cancer bone metastasis. Oncogene Yi Y, Wang C, Yu X. PMID: 42426271 [PubMed - as supplied by publisher]
	Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer. NPJ Precis Oncol Vaes RDW, Chen Z, Laven IEWG, Lyu S, Welbers TTJ, Piepers JAF, Hillen LM, von der Thüsen JH, Clarijs R, Decaudin D, Montaudon E, Blok MJ, Sprooten RTM, Hendriks LEL, Dursun S, Maessen JG, Degens JHRJ, Gronenschild MHM, Custers FLJ, de Loos ER, Dingemans AC, van Gent DC, Vooijs MA, De Ruysscher D. PMID: 42426227 [PubMed - as supplied by publisher]
	A multi-reader multi-case framework for evaluating the decision impact of emerging diagnostic tests for lung cancer. Sci Rep Hjorth-Hansen P, Wen SWC, Hansen TF, Nederby L, Andersen RF, Borg M, Jacobsen CM, Timm S, Pedersen MRV, Møller J, Hilberg O. PMID: 42426182 [PubMed - as supplied by publisher]
	The effect of Punicalagin on tongue carcinoma cells viability and angiogenesis by regulating TGF-Î² signalling pathway: an in vitro study. Sci Rep Ibrahim SSA, Farid SM, Fathy I, El-Khazragy N, Adel-Khattab D. PMID: 42426154 [PubMed - as supplied by publisher]
	Longitudinal utDNA dynamics predict recurrence risk in upper tract urothelial carcinoma: A prospective cohort study. Urol Oncol Zuo W, Tang Q, Guo X, Zhang J, Yu W, Zhang Y, Cheng H, Lin J, Zhou L, Li X. PMID: 42425884 [PubMed - as supplied by publisher]
	Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors. Urol Oncol Medina LG, Jaime-Casas S, Eskenazi F, Dugarte J, Chahoud J, Spiess PE. PMID: 42425883 [PubMed - as supplied by publisher]
	Evolution of germline testing, mutation spectrum and clinico-pathological features in male breast cancer: a 27-year retrospective cohort including 69 patients. Cancer Genet Taris N, Amand NDS, Hild C, Mathelin C, Chrétien M. PMID: 42425871 [PubMed - as supplied by publisher]
	Comment on: "Sentinel lymph node biopsy in recurrent and secondary oral cancer after neck dissection: a comparative study with primary tumours". Br J Oral Maxillofac Surg Bagchi P, Baviskar P, Yennemadi S. PMID: 42425870 [PubMed - as supplied by publisher]
	Re: Murthy V, Maitre P, Pal M, et al. Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-invasive Bladder Cancer. J Clin Oncol. In press. http://dx.doi.org/10.1200/JCO-25-02093. Eur Urol Miao J, Yi X. PMID: 42425857 [PubMed - as supplied by publisher]
	Neuron-tumor communication in solid tumors: from bona fide synapses to pseudo-synaptic neural interfaces. Trends Cancer Ren L, Liu C, Chen W, Wang Y, Rammes G, Neckel PH, Klingl A, Istvanffy R, Friess H, Ceyhan GO, Yang Q, Demir IE. PMID: 42425835 [PubMed - as supplied by publisher]
	Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study. Clin Colorectal Cancer Prata I, Nagtegaal ID, Hospers G, de Wilt JHW, Martinez CG, Hutschemaekers SAJ, Vanhoutvin S, Cats A, Marijnen CAM. PMID: 42425831 [PubMed - as supplied by publisher]
	Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. Eur Urol Focus Hoeh B, Mazzucato G, Tennstedt P, Ekrutt J, Preisser F, Budäus L, Maurer T, Graefen M, Tilki D, Mandel P, Steuber T. PMID: 42425812 [PubMed - as supplied by publisher]
	Efficacy and safety of TAS-102 followed by regorafenib or reverse sequence in later-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis. Chin Clin Oncol Sapapsap B, Champarhorm S, Pongpun A, Kanchana N, Tantivit J, Leelakanok N. PMID: 42425790 [PubMed - in process]
	Association of wearable device-based perioperative physical activity with recovery outcomes in patients undergoing lung cancer surgery: a systematic review and meta-analysis protocol. BMJ Open Su J, He Y, Shao F. PMID: 42425557 [PubMed - in process]

Articles 1 - 20 / 1953707

Page 1 of 97686



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy